☰

Michael E. Robbins, Ph.D.

Affiliations: 
University of Iowa, Iowa City, IA 
 2001-2012 Radiation Oncology Wake Forest University, Winston-Salem, NC, United States 
Area:
radiation oncology
Google:
"Michael Robbins"
Bio:

(1954–2012)
From http://www.pierce-jeffersonfuneralservice.com/memsol.cgi?user_id=827768: During his tenure at Wake Forest, Mike developed a world-class research program in the prevention and treatment of radiation-induced brain injury and was a senior leader in the Thomas K. Hearn Brain Tumor Center of Excellence. At the time of his death, Mike was principal investigator (PI), co-PI, or collaborator on 13 research grants from entities such as the National Cancer Institute, Department of Health and Human Services, and the Nuclear Regulatory Commission. Mike published 21 book chapters and over 120 research articles and mentored 20 graduate and post-doctoral students. His outstanding leadership and commitment to his colleagues in the laboratory created an atmosphere of genuine collaboration which led to the success of his team nationally and internationally. Mike lectured worldwide in his areas of academic expertise and was the recipient of numerous honors and awards.

Mean distance: 35622
 
Cross-listing: Neuropathology Tree

Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Geoffrey D. Girnun grad student 2000 University of Iowa
Weiling Zhao grad student 2000 University of Iowa

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kooshki M, Naczki C, Robbins ME, et al. (2015) Abstract 1792: Radiation-induced downregulation of GLT-1 glutamate transporter mRNA expression is reversed by renin-angiotensin system inhibitors Cancer Research. 75: 1792-1792
Greene-Schloesser D, Payne V, Peiffer AM, et al. (2014) The peroxisomal proliferator-activated receptor (PPAR) α agonist, fenofibrate, prevents fractionated whole-brain irradiation-induced cognitive impairment. Radiation Research. 181: 33-44
Moore ED, Kooshki M, Wheeler KT, et al. (2014) Differential expression of Homer1a in the hippocampus and cortex likely plays a role in radiation-induced brain injury. Radiation Research. 181: 21-32
Khoo NK, Hebbar S, Zhao W, et al. (2013) Differential activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy. Redox Biology. 1: 70-9
Moore ED, Kooshki M, Metheny-Barlow LJ, et al. (2013) Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling. Free Radical Biology & Medicine. 65: 1060-8
Schnegg CI, Greene-Schloesser D, Kooshki M, et al. (2013) The PPARδ agonist GW0742 inhibits neuroinflammation, but does not restore neurogenesis or prevent early delayed hippocampal-dependent cognitive impairment after whole-brain irradiation. Free Radical Biology & Medicine. 61: 1-9
Greene-Schloesser D, Moore E, Robbins ME. (2013) Molecular pathways: radiation-induced cognitive impairment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2294-300
Greene-Schloesser D, Robbins ME. (2012) Radiation-induced cognitive impairment--from bench to bedside. Neuro-Oncology. 14: iv37-44
Greene-Schloesser D, Robbins ME, Peiffer AM, et al. (2012) Radiation-induced brain injury: A review. Frontiers in Oncology. 2: 73
Lee TC, Greene-Schloesser D, Payne V, et al. (2012) Chronic administration of the angiotensin-converting enzyme inhibitor, ramipril, prevents fractionated whole-brain irradiation-induced perirhinal cortex-dependent cognitive impairment. Radiation Research. 178: 46-56
See more...